Lactiplantibacillus plantarum KABP-023 and Reduced Fecal Calprotectin Levels

• A Randomized, Double-Blind, Placebo-Controlled Trial to Assess the Efficacy and Safety of Lactiplantibacillus plantarum CJLP243 in Patients with Functional Diarrhea and High Fecal Calprotectin Levels

  • 2022-01-17
  • RCT · n = 24
  • Nutrients 14(2)
  • • Minah H. Jung
    • Susie Jung
    • Nam-Kyu Kim
    • H. Ahn
    • H. Yun
    • Kyu-Nam Kim

  • PubMed: 35057571
  • DOI: 10.3390/nu14020389

  4 Insights on

  • Reduced Fecal Calprotectin Levels

  • High evidence

  The probiotic group showed a statistically significant decrease in log-transformed FC values compared with the pre-treatment group, whereas the placebo group showed no difference before and after the intervention.

  Effect

  Beneficial

  Effect size

  Moderate

  Significant

  Yes